Remark Med (MARK) Reports Q2 Loss of $0.34/Share

August 9, 2012 9:05 AM

Remark Med (NASDAQ: MARK) reported Q2 EPS of ($0.34), versus ($0.19) reported last year.

For earnings history and earnings-related data on Remark Med (MARK) click here.

No results found